|
HIAT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.624200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.318500E-03 |
| Normal-vs-Stage2 |
1.795840E-03 |
| Normal-vs-Stage3 |
7.165200E-04 |
| Normal-vs-Stage4 |
7.422600E-04 |
| Stage1-vs-Stage2 |
2.605200E-01 |
| Stage1-vs-Stage3 |
2.673200E-01 |
| Stage1-vs-Stage4 |
2.652200E-01 |
| Stage2-vs-Stage3 |
7.745800E-01 |
| Stage2-vs-Stage4 |
9.597400E-01 |
| Stage3-vs-Stage4 |
8.052200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.299480E-03 |
| Normal-vs-AfricanAmerican |
3.517400E-01 |
| Normal-vs-Asian |
1.560350E-02 |
| Caucasian-vs-AfricanAmerican |
2.031200E-01 |
| Caucasian-vs-Asian |
9.708000E-01 |
| AfricanAmerican-vs-Asian |
3.066600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.435200E-04 |
| Normal-vs-Female |
2.521000E-03 |
| Male-vs-Female |
2.511600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.199600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.797700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.552100E-04 |
| Normal-vs-Age(81-100Yrs) |
6.202300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.337630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.348950E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.481000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.063800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.845800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.536400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.098200E-01 |
| Classical-VS-Follicular |
3.412800E-04 |
| Classical-VS-Other |
1.209570E-01 |
| Classical-VS-Normal |
2.664400E-02 |
| Tall-VS-Follicular |
3.127000E-01 |
| Tall-VS-Other |
3.156400E-01 |
| Tall-VS-Normal |
5.219500E-03 |
| Follicular-VS-Other |
7.381400E-01 |
| Follicular-VS-Normal |
1.67016999998992E-05 |
| Other-VS-Normal |
1.060500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.393130E-04 |
| Normal-vs-N1 |
3.440800E-04 |
| N0-vs-N1 |
5.030200E-01 |
|
|
